Vericel Corp. (VCEL)
35.53
+0.80
(+2.30%)
USD |
NASDAQ |
May 01, 16:00
35.53
0.00 (0.00%)
After-Hours: 20:00
Vericel EPS Diluted (Quarterly) : 0.4464 for Dec. 31, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Arbutus Biopharma Corp. | -0.0195 |
| Marker Therapeutics, Inc. | -0.1022 |
| Moderna, Inc. | -2.107 |
| Krystal Biotech, Inc. | 1.699 |
| Tenaya Therapeutics, Inc. | -0.1152 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | 23.24M |
| Revenue (Quarterly) | 92.92M |
| Total Expenses (Quarterly) | 69.68M |
| Enterprise Value | 1.724B |
| Gross Profit Margin (Quarterly) | 78.70% |
| Profit Margin (Quarterly) | 25.01% |
| Earnings Yield | 0.87% |
| Operating Earnings Yield | 0.61% |
| Normalized Earnings Yield | 0.8663 |